Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-25 @ 4:18 AM
NCT ID:
NCT00593320
Eligibility Criteria:
Inclusion Criteria:
* Signed informed consent.
* Age greater than or equal to 18 years old.
* Prior histologically-proven, non-hematogenous malignancy (Specific exclusions are multiple myeloma and lymphoma).
* Radiographic evidence of one or two non-contiguous spinal metastases amenable to SRS.
* Metastatic disease must be symptomatic (causing either pain or neurologic symptoms).
* Maximum tumor size less than or equal to 5 cm.
* Zubrod performance status of less than or equal to 3.
* Life expectancy of greater than or equal to 3 months.
* Women/Men of childbearing potential must use effective contraception.
Exclusion Criteria:
* No prior radiation delivered to the involved area
* No evidence of spinal instability requiring urgent surgical intervention.
* No evidence of spinal cord compression requiring emergent surgical or radiotherapeutic intervention.
* No plans for concomitant antineoplastic therapy (including standard fractionated RT, chemotherapy, biologic, vaccine therapy, or surgery) while on this protocol except at disease progression.Concomitant is defined as within 3 days before or after radiosurgery.
* No pregnant or lactating women.
* No active systemic infection.
* No evidence of myelopathy or cauda equina syndrome on clinical evaluation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00593320
Study Brief:
Protocol Section:
NCT00593320